Embryonic stem cells (ES cells) have significant potential in tissue engineering and regenerative medicine due to their ability to differentiate into any cell or tissue type in the body. This review discusses the history and current status of ES cell research, focusing on their potential for human disease treatment. ES cells were first isolated from mouse blastocysts in 1981 and later from human blastocysts in 1998. They can be maintained in an undifferentiated state and differentiated into various cell types when exposed to appropriate signals. ES cells have been used to study early embryonic development and to generate transgenic animals for gene research. Human ES cells have sparked ethical debates, particularly regarding the use of human embryos for research. Alternative methods, such as somatic nuclear transfer, have been explored but face ethical and technical challenges. ES cells can be differentiated into various somatic cell types in vitro, including cardiomyocytes, osteoblasts, neurons, and hepatocytes. However, challenges remain in ensuring the purity and functionality of these cells for clinical applications. ES cells also have potential for generating complex tissue constructs in three-dimensional environments. Despite their promise, obstacles such as immunocompatibility, ethical concerns, and technical limitations must be overcome before ES cell-based therapies can be widely applied in clinical settings. The development of human ES cells has been a major breakthrough in regenerative medicine, but significant challenges remain in translating this research into practical clinical applications.Embryonic stem cells (ES cells) have significant potential in tissue engineering and regenerative medicine due to their ability to differentiate into any cell or tissue type in the body. This review discusses the history and current status of ES cell research, focusing on their potential for human disease treatment. ES cells were first isolated from mouse blastocysts in 1981 and later from human blastocysts in 1998. They can be maintained in an undifferentiated state and differentiated into various cell types when exposed to appropriate signals. ES cells have been used to study early embryonic development and to generate transgenic animals for gene research. Human ES cells have sparked ethical debates, particularly regarding the use of human embryos for research. Alternative methods, such as somatic nuclear transfer, have been explored but face ethical and technical challenges. ES cells can be differentiated into various somatic cell types in vitro, including cardiomyocytes, osteoblasts, neurons, and hepatocytes. However, challenges remain in ensuring the purity and functionality of these cells for clinical applications. ES cells also have potential for generating complex tissue constructs in three-dimensional environments. Despite their promise, obstacles such as immunocompatibility, ethical concerns, and technical limitations must be overcome before ES cell-based therapies can be widely applied in clinical settings. The development of human ES cells has been a major breakthrough in regenerative medicine, but significant challenges remain in translating this research into practical clinical applications.